These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7334085)

  • 1. Autoimmunity in ocular and generalised myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT; Lawton J; Luciani G; McLeod J; Bradley J; Genkins G; Teng CS
    J Neuroimmunol; 1981 Sep; 1(3):325-32. PubMed ID: 7334085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
    Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
    Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody.
    Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S
    Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis.
    Isshiki Y; Mimura O; Gomi F
    Jpn J Ophthalmol; 2020 Nov; 64(6):628-634. PubMed ID: 32936398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ.
    Zimmermann CW; Eblen F
    Clin Investig; 1993 Jun; 71(6):445-51. PubMed ID: 8353403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies.
    Masters CL; Dawkins RL; Zilko PJ; Simpson JA; Leedman RJ
    Am J Med; 1977 Nov; 63(5):689-94. PubMed ID: 930944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis.
    Wang ZY; Diethelm-Okita B; Okita DK; Kaminski HJ; Howard JF; Conti-Fine BM
    J Neuroimmunol; 2000 Aug; 108(1-2):29-39. PubMed ID: 10900334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative modifications of blood serum proteins in myasthenia gravis.
    Adamczyk-Sowa M; Bieszczad-Bedrejczuk E; Galiniak S; Rozmiłowska I; Czyżewski D; Bartosz G; Sadowska-Bartosz I
    J Neuroimmunol; 2017 Apr; 305():145-153. PubMed ID: 28284335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
    Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
    Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiacetylcholine receptor antibodies and myasthenia gravis.
    Richter PL
    JAMA; 1982 Jun; 247(22):3082-3. PubMed ID: 7077800
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiacetylcholine receptor antibodies and myasthenia gravis.
    Fulpius BW
    Int Rev Neurobiol; 1983; 24():1-14. PubMed ID: 6197385
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to treatment in pediatric ocular myasthenia gravis.
    Xu L; Castro D; Reisch JS; Iannaccone ST
    Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiacetylcholine receptor antibody in juvenile myasthenia gravis].
    Onoe S; Abe J; Tagawa T; Ono J; Mimaki T; Yabuuchi H; Hayashi M; Kida K; Sugita T
    No To Hattatsu; 1984 Jan; 16(1):4-10. PubMed ID: 6712842
    [No Abstract]   [Full Text] [Related]  

  • 18. Low conversion rate of ocular to generalized myasthenia gravis in Singapore.
    Teo KY; Tow SL; Haaland B; Gosavi TD; Jing-Liang L; Yew Long LO; Milea D
    Muscle Nerve; 2018 May; 57(5):756-760. PubMed ID: 28981152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients.
    Zhang Y; Zhang X; Xia Y; Jia X; Li H; Zhang Y; Shao Z; Xin N; Guo M; Chen J; Zheng S; Wang Y; Fu L; Xiao C; Geng D; Liu Y; Cui G; Dong R; Huang X; Yu T
    Immunol Res; 2016 Dec; 64(5-6):1216-1224. PubMed ID: 27677768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some clinico-immunological aspects in patients with ocular myasthenia gravis associated with inflammatory bowel disease.
    Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Atanasiu AN; Mitu AC; Iliescu I; Dumitrescu L
    Rom J Intern Med; 2008; 46(2):165-8. PubMed ID: 19284089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.